Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Hyperplasia × Eicosapentaenoic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polyps 2 Hyperplasia 2 Adenomatous Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Endoscopy 2 Eicosapentaenoic Acid 2 Restraint, Physical 1 Colonoscopy 1 Clinical Chemistry Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed

58 enrolled 12 charts

Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡